New immunotherapy approach targets HER2-positive breast cancer
A new technique aimed at harnessing the body’s immune system to attack one of the deadliest forms of breast cancer is being developed by British scientists.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units